After 2 decades on the market, compelling evidence is building that the retropubic, transobturator, & minisling devices cause catastrophic health complications.
SANTA BARBARA, CA, UNITED STATES, May 16, 2019 /EINPresswire.com/ — Commonly called the ‘Gold Standard’ for the treatment of stress urinary incontinence, grave concern exists because the long-term safety of the synthetic sling has never been established. Quoting a recent JAMA article, the device was brought to the market with ‘no high-quality randomized controlled trials’ to support their use.
Alarmingly, after two decades on the market, compelling evidence has been building that the retropubic, transobturator, and minisling devices cause catastrophic health complications.
Because these products are dangerous, transvaginal mesh (TVM) devices used for pelvic organ prolapse have been removed from the market as ordered by the FDA. Yet, polypropylene slings continue to be the mainstay in surgical treatment of stress urinary incontinence. Surgeons are no longer trained to perform the traditional autologous sling procedures, which use the patient’s own tissue and avoids the severe complications caused by the synthetic slings. Dr. Linda Brubaker from the University of California, San Diego states that, “Younger surgeons aren’t even learning how to perform incontinence procedures that don’t use mesh.”
Dr. Greg Vigna, a practicing physician, Certified Life Care Planner, and national pharmaceutical injury attorney states, “Autologous slings simply haven’t caused the catastrophic neurological complications observed in synthetic polypropylene slings.”
Retropubic slings cause acute and then chronic ilioinguinal neuralgia and pudendal neuralgia from injury to the clitoral branch. Transobturator slings and mini-slings cause acute then chronic obturator neuralgia and pudendal neuralgia.
Dr. Vigna reports, “All synthetic polypropylene slings may cause complex regional pain syndrome. For unknowing women, these diagnoses lead to life-altering problems that require expert medical evaluation and treatment which isn’t widely available.”
Working with a team of prominent national pharmaceutical injury attorneys, Dr. Vigna is investigating new neurological complications caused by synthetic polypropylene sling devices including the Johnson & Johnson TVT-O and TVT, Boston Scientific Solyx and Obtryx, and Coloplast Aris and Altis.
Dr. Vigna has evaluated the medical records of sling related complications, “In a vast majority of cases there is no indication of physician error. These complications may not appear initially but occur years after implantation. Now that the MDL (Multi-District Litigation) is closed to new cases, we are filing individual cases in State Courts across the country and developing them for trial. We are committed to giving our clients their day in court.”
For more resources and information, including Dr. Vigna’s newest eBook titled “Sling Complications” visit our website or call 800-761-9206.
Greg Vigna, M.D., J.D.
email us here
Source: EIN Presswire